24/7 Wall St. on MSN3h
I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the GameThe biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it's really tough to gauge which innovative biotech firms will have something genuinely ground ...
Novo Nordisk A/S, GE HealthCare Technologies Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com ...
Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.
There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as ...
When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...
It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Exxon Mobil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback